Patents by Inventor Judith M. Leon

Judith M. Leon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin
    Patent number: 8557256
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: October 15, 2013
    Assignee: Allergan, Inc.
    Inventors: Kei Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Botulinum toxin treatments
    Patent number: 8486886
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: July 16, 2013
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Stephen R. Carlson, Judith M. Leon
  • BOTULINUM TOXIN TREATMENTS
    Publication number: 20120232022
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: May 22, 2012
    Publication date: September 13, 2012
    Applicant: ALLERGAN INC.
    Inventors: K. Roger AOKI, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Botulinum toxin treatments
    Patent number: 8216995
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: July 10, 2012
    Assignee: Allergan, Inc.
    Inventors: Kei Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle
    Patent number: 8187612
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: December 2, 2003
    Date of Patent: May 29, 2012
    Assignee: Allergan, Inc.
    Inventors: Kei Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Use of the neurotoxic component of a botulinum toxin for treating arthritis
    Patent number: 8052980
    Abstract: A method for treating a patient suffering from arthritis and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxic component of neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: November 8, 2011
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Use of the neurotoxic component of a botulinum toxin for treating arthritis
    Publication number: 20090318360
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: August 28, 2009
    Publication date: December 24, 2009
    Applicant: ALLERGAN, INC.
    Inventors: K. Roger AOKI, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • TREATMENT OF POST-STROKE MUSCLE PAIN
    Publication number: 20090123498
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: March 13, 2008
    Publication date: May 14, 2009
    Applicant: ALLERGAN, INC
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Methods for treating myofascial pain
    Patent number: 7501130
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: April 13, 2006
    Date of Patent: March 10, 2009
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • BOTULINUM TOXIN TREATMENTS
    Publication number: 20080213313
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 4, 2008
    Applicant: ALLERGAN, INC.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • BOTULINUM TOXIN TREATMENTS
    Publication number: 20080213312
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 4, 2008
    Applicant: ALLERGAN, INC.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Methods for treating pain associated with arthritis
    Patent number: 7381700
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: June 22, 2005
    Date of Patent: June 3, 2008
    Assignee: Allergan, Inc.
    Inventors: Kei Roger Aoki, Micheal W. Grayston, Steven R. Carlson, Judith M. Leon
  • USE OF THE NEUROTOXIC COMPONENT OF A BOTULINUM TOXIN FOR TREATING A SPASTIC MUSCLE
    Publication number: 20080107763
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: April 26, 2007
    Publication date: May 8, 2008
    Applicant: ALLERGAN, INC.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • NEUROTOXIN COMPONENT TREATMENT FOR SPASTICITY
    Publication number: 20080107762
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Application
    Filed: April 26, 2007
    Publication date: May 8, 2008
    Applicant: ALLERGAN, INC.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Methods for treating arthritis pain
    Patent number: 7091176
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: July 16, 2003
    Date of Patent: August 15, 2006
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Method for treating secretions and glands using botulinum toxin
    Patent number: 6974578
    Abstract: Method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of, Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: April 3, 1996
    Date of Patent: December 13, 2005
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Use of botulinum toxins for treating various disorders and conditions and associated pain
    Patent number: 6896886
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: July 16, 2001
    Date of Patent: May 24, 2005
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Method for treating pain with botulinum toxin type B
    Patent number: 6887476
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: May 3, 2005
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Method for treating neuromuscular disorders and conditions with botulinum toxin types A and B
    Patent number: 6872397
    Abstract: A method of treating a patient suffering from a disease, disorder or condition includes the administration to the patient of a therapeutically effective amount of botulinum toxin of a selected serotype until the patient experiences loss of clinical response to the administered botulinum toxin and thereafter administering to the patient a therapeutically effective amount of another botulinum toxin of a different serotype.
    Type: Grant
    Filed: March 15, 2001
    Date of Patent: March 29, 2005
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
  • Method for treating essential tremor with botulinum toxin type B
    Patent number: 6861058
    Abstract: A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
    Type: Grant
    Filed: June 15, 2001
    Date of Patent: March 1, 2005
    Assignee: Allergan, Inc.
    Inventors: K. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon